José Luis Alonso-Romero

12PUBLICATIONS
78CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Forensic psychologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 27, 2026
Restoring Physiological Normoxia as an Adjuvant Strategy to Improve Cancer Treatment Outcomes.

|Mar 14, 2026
Clinical Complete Response and Organ Preservation Strategies in Rectal Cancer: A Real-World Single-Center Experience Clinical Complete Response and Organ Preservation in Rectal Cancer.

J A Encarnación, N Ibáñez, I De la Fuente

|Jan 06, 2026
Drug-drug interactions in adjuvant and neoadjuvant breast cancer therapy.

Miguel Almanchel-Rivadeneyra, José Luis Alonso Romero, Aina Tomás-Luiz

|Dec 30, 2025
Bone Health in Metastatic Hormone-Sensitive Prostate Cancer: Where We Stand and Where We Can Improve.

Juan Antonio Encarnación, Enrique López-Jiménez, Jose Luis Alonso-Romero

|Oct 29, 2025
miR-106b-5p as a Central Regulator of Cancer Progression and Chemotherapy-Induced Cardiotoxicity: From Molecular Mechanisms to Clinical Translation.

Maria Del Carmen Asensio Lopez, Miriam Ruiz Ballester, Francisco Jose Bastida Nicolas

|Oct 24, 2025
Incidence and Survival of IDH-Wildtype Glioblastoma and IDH-Mutant Astrocytoma by Treatment and Sex: A Regional Study in Spain (2011-2021).

J A Encarnación, C Manso, M Royo-Villanova

Pageof 2

Frequent Collaborators

5 joint publications

Juan Antonio Encarnación

2 joint publications

Paula Ruiz

2 joint publications

Mario Royo-Villanova

2 joint publications

Pablo Luis Guzman Martínez-Valls